@article{48dffabf15594d319e3b225df36a03ff,
title = "Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial.",
keywords = "POSTMENOPAUSAL WOMEN, ANTITUMOR-ACTIVITY, OVARIAN ABLATION, AUSTRIAN BREAST, ORAL CLODRONATE, TUMOR-CELLS, ZO-FAST, BISPHOSPHONATES, SURVIVAL, CHEMOTHERAPY",
author = "Michael Gnant and Brigitte Mlineritsch and Herbert Stoeger and Gero Luschin-Ebengreuth and Dietmar Heck and Christian Menzel and Raimund Jakesz and Michael Seifert and Michael Hubalek and Gunda Pristauz and Thomas Bauernhofer and Holger Eidtmann and Wolfgang Eiermann and Guenther Steger and Werner Kwasny and Peter Dubsky and Gerhard Hochreiner and Ernst-Pius Forsthuber and Christian Fesl and Richard Greil",
note = "Paracelsus Medical University Salzburg, Salzburg, Austria",
year = "2011",
doi = "10.1016/S1470-2045(11)70122-X",
language = "English",
volume = "12",
pages = "63--41",
journal = "LANCET ONCOL",
issn = "1470-2045",
publisher = "Elsevier ",
number = "7",
}